Triall (TRL) is a token of an end-to-end platform for data collection and research management. Triall solutions are designed to support any therapeutic area, research design, and research phase. The platform offers advanced integration capabilities with websites, mobile devices and wearables to support remote data collection and study management.

Triall (TRL) news

Triall

Telegram

Triall Insights 🔍

According to the IQVIA Institute, 300 new molecular entities (‘NMEs’) are expected to be approved between 2022 and 2026. 

The influx of NMEs demonstrates the need for specialised software that supports reliable and cost-efficient clinical trials to bring these entities to market.

⚡️ Trade $TRL at bit.ly/tradeTRL

🗣 Help us spread the news on Twitter:
https://twitter.com/triallofficial/status/1670767748819943426?s=20

#blockchainforhealth #TRL

Triall Insights.